Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jul 24, 2014
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received an AB therapeutic equivalent rating from the U.S. Food and Drug Administration (FDA) for its previously approved New Drug...
-
Jul 8, 2014
Perrigo Company (NYSE: PRGO; TASE) today announced that it was the first to receive final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for ibuprofen...
-
Jun 20, 2014
Perrigo Company plc (NYSE: PRGO; TASE) and its partner, Catalent, announced today that they have settled their first to file Hatch Waxman litigation with Teva with respect to a generic version of...
-
May 30, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Jefferies 2014 Global Healthcare Conference on Monday, June 2,...
-
May 12, 2014
Perrigo Company plc (NYSE: PRGO;TASE) announced that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for azelastine...
-
May 7, 2014
Fiscal third quarter net sales increased 9% year-over-year to a record $1,004 million. Fiscal third quarter adjusted net income increased 31% to $176 million, or $1.31 per diluted share; GAAP net...
-
Apr 28, 2014
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.105 per share, payable on June 17, 2014 to shareholders of record on May 30, 2014.
-
Apr 28, 2014
Thousands of law enforcement K-9s put their lives on the line to protect America on a daily basis. They are usually the first officer to enter a dangerous situation and help track and neutralize...
-
Apr 23, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its third quarter fiscal year 2014 on Wednesday, May 7, 2014 at approximately 8:00 a.m. (ET). The...
-
Apr 1, 2014
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has initiated market launch and made its first shipments of the authorized generic version of...